Peptide Name: BPC-157 (Body Protection Compound-157) Alias: Wolverine peptide Molecular Formula: CHNO Molecular Weight: ~1419.5 g/mol Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Purity: 99% (HPLC verified) Appearance: White to off-white lyophilized powder Form: Sterile freeze-dried vial Storage: -20C recommended for long-term stability Solubility: Water-soluble in laboratory buffer solutions These specifications make high purity BPC-157 suitable for controlled experimental environments requiring consistency and analytical reliability
It is not the same as AHK-Cu, a related tripeptide-copper complex (Ala-His-Lys with copper) that shares the histidine-anchored coordination chemistry but has different specific biological characterization
It is not approved by the FDA for clinical use, diagnostics, or therapeutic procedures in humans or animals
When those same patients transition to a properly formulated injectable protocol, the clinical picture changes within weeks
Its unique mechanism has made it one of the most extensively studied peptides for exploring the biological processes associated with cellular aging and long-term tissue maintenance
However, inhibition of checkpoint proteins has established ways to overcome immunosuppression and evolved cancer immunotherapy [68]